Cargando…

E-prescribing and access to prescription medicines during lockdown: experience of patients in Aotearoa/New Zealand

BACKGROUND: Health services internationally have been compelled to change their methods of service delivery in response to the global COVID-19 pandemic, to mitigate the spread of infection amongst health professionals and patients. In Aotearoa/New Zealand, widespread electronic delivery of prescript...

Descripción completa

Detalles Bibliográficos
Autores principales: Imlach, Fiona, McKinlay, Eileen, Kennedy, Jonathan, Morris, Caroline, Pledger, Megan, Cumming, Jacqueline, McBride-Henry, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247618/
https://www.ncbi.nlm.nih.gov/pubmed/34210271
http://dx.doi.org/10.1186/s12875-021-01490-0
_version_ 1783716554471374848
author Imlach, Fiona
McKinlay, Eileen
Kennedy, Jonathan
Morris, Caroline
Pledger, Megan
Cumming, Jacqueline
McBride-Henry, Karen
author_facet Imlach, Fiona
McKinlay, Eileen
Kennedy, Jonathan
Morris, Caroline
Pledger, Megan
Cumming, Jacqueline
McBride-Henry, Karen
author_sort Imlach, Fiona
collection PubMed
description BACKGROUND: Health services internationally have been compelled to change their methods of service delivery in response to the global COVID-19 pandemic, to mitigate the spread of infection amongst health professionals and patients. In Aotearoa/New Zealand, widespread electronic delivery of prescriptions (e-prescribing) was enabled. The aim of the research was to explore patients’ experiences of how lockdown, changes to prescribing and the interface between general practices and community pharmacy affected access to prescription medications. METHOD: The research employed a mixed-method approach. This included an online survey (n = 1,010) and in-depth interviews with a subset of survey respondents (n = 38) during the first COVID-19 lockdown (March–May 2020). Respondents were recruited through a snowballing approach, starting with social media and email list contacts of the research team. In keeping with the approach, descriptive statistics of survey data and thematic analysis of qualitative interview and open-ended questions in survey data were combined. RESULTS: For most respondents who received a prescription during lockdown, this was sent directly to the pharmacy. Most people picked up their medication from the pharmacy; home delivery of medication was rare (4%). Survey and interview respondents wanted e-prescribing to continue post-lockdown and described where things worked well and where they encountered delays in the process of acquiring prescription medication. CONCLUSIONS: E-prescribing has the potential to improve access to prescription medication and is convenient for patients. The increase in e-prescribing during lockdown highlighted how the system could be improved, through better feedback about errors, more consistency across practices and pharmacies, more proactive communication with patients, and equitable prescribing costs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12875-021-01490-0.
format Online
Article
Text
id pubmed-8247618
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82476182021-07-02 E-prescribing and access to prescription medicines during lockdown: experience of patients in Aotearoa/New Zealand Imlach, Fiona McKinlay, Eileen Kennedy, Jonathan Morris, Caroline Pledger, Megan Cumming, Jacqueline McBride-Henry, Karen BMC Fam Pract Research BACKGROUND: Health services internationally have been compelled to change their methods of service delivery in response to the global COVID-19 pandemic, to mitigate the spread of infection amongst health professionals and patients. In Aotearoa/New Zealand, widespread electronic delivery of prescriptions (e-prescribing) was enabled. The aim of the research was to explore patients’ experiences of how lockdown, changes to prescribing and the interface between general practices and community pharmacy affected access to prescription medications. METHOD: The research employed a mixed-method approach. This included an online survey (n = 1,010) and in-depth interviews with a subset of survey respondents (n = 38) during the first COVID-19 lockdown (March–May 2020). Respondents were recruited through a snowballing approach, starting with social media and email list contacts of the research team. In keeping with the approach, descriptive statistics of survey data and thematic analysis of qualitative interview and open-ended questions in survey data were combined. RESULTS: For most respondents who received a prescription during lockdown, this was sent directly to the pharmacy. Most people picked up their medication from the pharmacy; home delivery of medication was rare (4%). Survey and interview respondents wanted e-prescribing to continue post-lockdown and described where things worked well and where they encountered delays in the process of acquiring prescription medication. CONCLUSIONS: E-prescribing has the potential to improve access to prescription medication and is convenient for patients. The increase in e-prescribing during lockdown highlighted how the system could be improved, through better feedback about errors, more consistency across practices and pharmacies, more proactive communication with patients, and equitable prescribing costs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12875-021-01490-0. BioMed Central 2021-07-01 /pmc/articles/PMC8247618/ /pubmed/34210271 http://dx.doi.org/10.1186/s12875-021-01490-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Imlach, Fiona
McKinlay, Eileen
Kennedy, Jonathan
Morris, Caroline
Pledger, Megan
Cumming, Jacqueline
McBride-Henry, Karen
E-prescribing and access to prescription medicines during lockdown: experience of patients in Aotearoa/New Zealand
title E-prescribing and access to prescription medicines during lockdown: experience of patients in Aotearoa/New Zealand
title_full E-prescribing and access to prescription medicines during lockdown: experience of patients in Aotearoa/New Zealand
title_fullStr E-prescribing and access to prescription medicines during lockdown: experience of patients in Aotearoa/New Zealand
title_full_unstemmed E-prescribing and access to prescription medicines during lockdown: experience of patients in Aotearoa/New Zealand
title_short E-prescribing and access to prescription medicines during lockdown: experience of patients in Aotearoa/New Zealand
title_sort e-prescribing and access to prescription medicines during lockdown: experience of patients in aotearoa/new zealand
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247618/
https://www.ncbi.nlm.nih.gov/pubmed/34210271
http://dx.doi.org/10.1186/s12875-021-01490-0
work_keys_str_mv AT imlachfiona eprescribingandaccesstoprescriptionmedicinesduringlockdownexperienceofpatientsinaotearoanewzealand
AT mckinlayeileen eprescribingandaccesstoprescriptionmedicinesduringlockdownexperienceofpatientsinaotearoanewzealand
AT kennedyjonathan eprescribingandaccesstoprescriptionmedicinesduringlockdownexperienceofpatientsinaotearoanewzealand
AT morriscaroline eprescribingandaccesstoprescriptionmedicinesduringlockdownexperienceofpatientsinaotearoanewzealand
AT pledgermegan eprescribingandaccesstoprescriptionmedicinesduringlockdownexperienceofpatientsinaotearoanewzealand
AT cummingjacqueline eprescribingandaccesstoprescriptionmedicinesduringlockdownexperienceofpatientsinaotearoanewzealand
AT mcbridehenrykaren eprescribingandaccesstoprescriptionmedicinesduringlockdownexperienceofpatientsinaotearoanewzealand